Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 715 of 1,261
  1. US 9228053

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Nektar Therapeutics · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  2. US 9228007

    Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells

    The Regents of the University of California · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  3. US 9228002

    Leishmania vaccine using sand fly salivary immunogen

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  4. US 9227995

    Peptides

    DRUG DISCOVERY LABORATORY AS · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  5. US 9227933

    3-phenoxymethylpyrrolidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  6. US 9227044

    Applicator for applying a fluid to a surface

    AMNEAL PHARMACEUTICALS LLC · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  7. US 9228001

    Mutants of cholesterol-dependent cytolysins and uses thereof

    The Board of Regents of the University of Oklahoma · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  8. US 9226971

    N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

    Nektar Therapeutics · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  9. US 9227918

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  10. US 9226969

    Salt form of a multi-arm polymer-drug conjugate

    Nektar Therapeutics · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  11. US 9226930

    1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  12. US 9226955

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Providence Health & Services—Oregon · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  13. US 9226937

    Compositions containing resveratrol and nucleotides

    RESVERATROL PARTNERS, LLC · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  14. US 9226919

    Methods for dosing an orally active 1,2,4-oxadiazole

    PTC THERAPEUTICS, INC. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  15. US 9226910

    Treatment for obesity

    Jazz Pharmaceuticals International III Limited · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  16. US 9226896

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  17. US 9228188

    Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression

    Alnylam Pharmaceuticals, Inc. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  18. EP 2958945

    KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS

    GANYMED PHARMACEUTICALS AG [DE] · Granted Dec 30, 2015 · Expires Dec 25, 2035

    granted
  19. US 9220706

    Inhibition of leukemic stem cells by PP2A activating agents

    THE UNITED STATES OF AMERICA NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  20. US 9221772

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  21. US 9220748

    Macrocyclic proline derived HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  22. US 9220733

    Solubilization of antigen components for removal from tissues

    The Regents of the University of California · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  23. US 9220735

    Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

    AKER BIOMARINE ANTARCTIC AS · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  24. US 9222142

    Adenoviruses and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.